{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6505121",
  "DateCompleted": {
    "Year": "1985",
    "Month": "01",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "02",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0254-4962",
      "JournalIssue": {
        "Volume": "17 Suppl 3",
        "PubDate": {
          "Year": "1984"
        }
      },
      "Title": "Psychopathology",
      "ISOAbbreviation": "Psychopathology"
    },
    "ArticleTitle": "Fear and anxiety: relationship to noradrenergic function.",
    "Pagination": {
      "StartPage": "8",
      "EndPage": "23",
      "MedlinePgn": "8-23"
    },
    "Abstract": {
      "AbstractText": [
        "The experiences of human fear and anxiety are discussed within the context of locus ceruleus function in animals. The rationale for studying correlates of noradrenergic function, such as 3-methoxy-4-hydroxyphenethylene glycol (MHPG), is reviewed, and data demonstrating a positive correlation between plasma free MHPG and state anxiety in normal volunteers is presented. The behavioral effects of oral caffeine (240-720 mg), intravenous clonidine (2 micrograms/kg), and oral yohimbine (20 mg) were studied in various psychiatric patients and normal volunteers. Caffeine and yohimbine had anxiogenic properties; conversely, clonidine reduced self-rated measures of anxiety across a wide spectrum of psychiatric conditions. These findings expand previous research indicating that noradrenergic hyperactivity may be associated with many types of human fear and anxiety."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Uhde",
        "ForeName": "T W",
        "Initials": "TW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Boulenger",
        "ForeName": "J P",
        "Initials": "JP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Post",
        "ForeName": "R M",
        "Initials": "RM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Siever",
        "ForeName": "L J",
        "Initials": "LJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Vittone",
        "ForeName": "B J",
        "Initials": "BJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Jimerson",
        "ForeName": "D C",
        "Initials": "DC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Roy-Byrne",
        "ForeName": "P P",
        "Initials": "PP"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Psychopathology",
    "NlmUniqueID": "8401537",
    "ISSNLinking": "0254-4962"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "3G6A5W338E",
      "NameOfSubstance": "Caffeine"
    },
    {
      "RegistryNumber": "MN3L5RMN02",
      "NameOfSubstance": "Clonidine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "chemically induced",
        "drug therapy",
        "physiopathology",
        "prevention & control"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Caffeine"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Clonidine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dose-Response Relationship, Drug"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Fear"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Locus Coeruleus"
    },
    {
      "QualifierName": [
        "physiology",
        "physiopathology"
      ],
      "DescriptorName": "Sympathetic Nervous System"
    }
  ]
}